•
•
(36), 133 (93), 147 (86) [M+ −89], 191 (100) [M+ −45], 236 (64)
General procedure for preparation of bis(imidazolium) salts
5b·2Cl, 6b·2Br and 7b·2Br. Halides 1, 2 or 3 (1 equiv) and 1-
mesityl-1H-imidazole 4b (1 equiv) were dissolved in dry DMF
and heated to 100 ◦C under an argon atmosphere for 12 h and the
solvent was then removed under vacuum. The solids obtained were
washed several times with dry acetone and used without further
purification. The yields were not optimized.
•
•
[M+ ], 237 (12) [M+ + 1].
2,4-Bis(3-bromopropyl)-1,3,5-trimethylbenzene 3. To alcohol
14 (6.34 g, 26.84 mmol) was added 48% hydrobromic acid
(21.5 mL, 402.70 mmol), at 0 ◦C. The resulting mixture was
heated at reflux temperature for 12 h. The reaction solution was
cooled and then water (100 mL) was added. The resulting mixture
was extracted with CH2Cl2 (3 × 250 mL). The organic layers
were dried (anhydrous Na2SO4), filtered and concentrated under
reduced pressure to obtain bromide 3 (8.56 g, 88% yield) as a
brown oil. Mp 58–60 ◦C. 1H NMR (300 MHz, CDCl3): d = 1.97–
2.05 (m, 4H, CH2), 2.30 (s, 6H, CH3), 2.31 (s, 3H, CH3), 2.80
(t, J = 6.8 Hz, 4H, Ar–CH2), 3.53 (t, J = 6.8 Hz, 4H, CH2Br),
6.87 (s, 1H) ppm. 13C NMR (75.4 MHz, CDCl3): d = 15.3 (CH3),
19.9 (CH3), 28.8 (Ar–CH2), 32.3 (CH2), 34.0 (CH2Br), 130.1 (CH),
3,3ꢀ-[(2,4,6-Trimethyl-1,3-phenylene)bis(methylene)]bis[1-(2,4,6-
trimethylphenyl)-1H-imidazol-3-ium] dichloride 5b·2Cl. The
above procedure was followed using 2,4-bis(chloromethyl)-
1,3,5-trimethylbenzene 1 (1.08 g, 4.98 mmol) and 1-mesityl-1H-
imidazole 4b (1.85 g, 9.95 mmol) and dry DMF (10 mL). The
product was obtained as a solid with 98% yield. Mp 94–96 ◦C.
1H NMR (400 MHz, DMSO-d6): d = 1.95 (s, 12H, CH3), 2.18 (s,
6H, CH3), 2.31 (s, 6H, CH3), 2.47 (s, 3H, CH3), 3.26 (t, 4H, J =
7.4 Hz, CH2), 4.46 (t, 4H, J = 7.4 Hz, CH2-Imi), 7.12 (s, 4H),
7.24 (s, 1H), 7.93 (Imi), 8.20 (Imi), 9.50 (Imi) ppm. 13C NMR
(100.6 MHz, DMSO-d6): d = 15.9 (CH3), 17.0 (CH3), 20.0 (CH3),
20.7 (CH3), 30.2 (CH2), 48.3 (CH2-Imi), 123.8 (Imi), 128.9 (Imi),
129.4 (CH), 130.3 (CH), 131.2, 131.5, 134.4, 135.4, 136.2, 137.6
(Imi), 140.4 ppm. ESI(+)-MS: m/z (%): 273.4 (100) [M]2+, 626.7
(11) [M + Br]+. Anal. Calcd for C37H46Br2N4·H2O: C, 61.33; H,
6.68; N, 7.73; found: C, 61.41; H, 7.01; N, 7.49.
•
133.8, 134.2, 135.7 ppm. EI-MS: m/z (%): 147 (29), 253 (100) [M+
•
•
•
−109], 255 (98) [M+ −107], 362 (25) [M+ ], 363 (4) [M+ + 1], 364
•
(12) [M+ + 2].
General procedure for preparation of bis(imidazolium) dibromides
6a·2Br and 7a·2Br. Bromides 2 or 3 were dissolved in 1-methyl-
1H-imidazole 4a and heated at reflux temperature for 30 min,
under argon atmosphere. After cooling to room temperature and
reduction of the volume, the residue was ground several times
with dry acetone. The resulting solid was filtered and used without
further purification. The yields were not optimized.
3,3ꢀ-(2,4,6-Trimethyl-1,3-phenylenediethane-2,1-diyl)bis[1-(2,4,6-
trimethyl)-1H-imidazol-3-ium] dibromide 6b·2Br. The above pro-
cedure was followed using 2,4-bis(2-bromoethyl)-1,3,5-trimethyl-
benzene 2 (2.50 g, 7.48 mmol) and 1-mesityl-1H-imidazole 4b
(2.86 g, 15.33 mmol) and dry DMF (15 mL). The product was
obtained as a hygroscopic foam with 97% yield. Mp 94–96 ◦C.
1H NMR (400 MHz, DMSO-d6): d = 1.95 (s, 12H, CH3), 2.18 (s,
6H, CH3), 2.31 (s, 6H, CH3), 2.47 (s, 3H, CH3), 3.26 (t, 4H, J =
7.4 Hz, CH2), 4.46 (t, 4H, J = 7.4 Hz, CH2-Imi), 7.12 (s, 4H),
7.24 (s, 1H), 7.93 (Imi), 8.20 (Imi), 9.50 (Imi) ppm. 13C NMR
(100.6 MHz, DMSO-d6): d = 15.9 (CH3), 17.0 (CH3), 20.0 (CH3),
20.7 (CH3), 30.2 (CH2), 48.3 (CH2-Imi), 123.8 (Imi), 128.9 (Imi),
129.4 (CH), 130.3 (CH), 131.2, 131.5, 134.4, 135.4, 136.2, 137.6
(Imi), 140.4 ppm. ESI(+)-MS: m/z (%): 273.4 (100) [M]2+, 626.7
(11) [M + Br]+. Anal. Calcd for C37H46Br2N4·H2O: C, 61.33; H,
6.68; N, 7.73; found: C, 61.41; H, 7.01; N, 7.49.
3,3ꢀ-(2,4,6-Trimethyl-1,3-phenylenediethane-2,1-diyl)bis(1-meth-
yl-1H-imidazol-3-ium) dibromide 6a·2Br. The above procedure
was followed using 2,4-bis(2-bromoethyl)-1,3,5-trimethylbenzene
2 (1.00 g, 2.99 mmol) and 1-methyl-1H-imidazole 4a (6.24 mL,
78.64 mmol). The product was obtained as a hygroscopic solid
with 76% yield. Mp 137–139 ◦C. 1H NMR (400 MHz, DMSO-d6):
d = 2.22 (s, 6H, CH3), 2.28 (s, 3H, CH3), 3.12 (t, 4H, J = 6.8 Hz,
CH2), 3.88 (s, 6H, Imi-CH3), 4.24 (t, 4H, J = 6.8 Hz, CH2-Imi),
6.88 (s, 1H), 7.76 (s, 2H, Imi), 7.85 (s, 2H, Imi), 9.37 (s, 2H, Imi)
ppm. 13C NMR (100.6 MHz, DMSO-d6): d = 15.5 (CH3), 19.9
(CH3), 30.6 (CH2), 36.0 (Imi-CH3), 47.6 (CH2-Imi), 122.7 (Imi),
123.6 (Imi), 130.3, 131.5 (CH), 135.3, 135.8, 136.9 (Imi) ppm. IR
−1
=
(KBr): m = 1565 (C N) cm . ESI(+)-MS: m/z (%): 169.3 (100)
[M]2+, 418.4 (2) [M + Br]+. Anal. Calcd for C21H30Br2N4·2 H2O:
C, 47.21; H, 6.41; N, 10.49; found: C, 47.21; H, 6.16; N, 10.28.
3,3ꢀ-(2,4,6-Trimethyl-1,3-phenylenedipropane-3,1-diyl)bis[1-(2,4,
6-trimethyl)-1H-imidazol-3-ium] dibromide 7b·2Br. The above
procedure was followed using 2,4-bis(3-bromopropyl)-1,3,5-
trimethylbenzene 3 (0.50 g, 7.48 mmol) and 1-mesityl-1H-
imidazole 4b (0.53 g, 2.83 mmol) and dry DMF (3 mL). The
product was obtained as a white solid with 77% yield. Mp
218–220 ◦C. 1H NMR (400 MHz, DMSO-d6): d = 1.93–1.98 (m,
4H, CH2), 2.03 (s, 12H, CH3), 2.14 (s, 9H, CH3), 2.33 (s, 6H, CH3),
2.49–2.55 (m, 4H, Ar–CH2), 4.43 (t, J = 7.0 Hz, 4H, CH2-Imi),
6.80 (s, 1H), 7.15 (s, 4H), 7.98 (s, 2H, Imi), 8.22 (s, 2H, Imi), 9.59
(s, 2H, Imi) ppm. 13C NMR (100.6 MHz, DMSO-d6): d = 14.9
(CH3), 17.1 (CH3), 19.6 (CH3), 20.8 (CH3), 26.3 (Ar–CH2), 29.1
(CH2), 49.8 (CH2-Imi), 123.6 (Imi), 124.1 (Imi), 129.4 (CH), 130.0
3,3ꢀ-(2,4,6-Trimethyl-1,3-phenylenedipropane-3,1-diyl)bis(1-meth-
yl-1H-imidazol-3-ium) dibromide 7a·2Br. The above proce-
dure was followed using 2,4-bis(3-bromopropyl)-1,3,5-trimethyl-
benzene 3 (0.50 g, 1.38 mmol) and 1-methyl-1H-imidazole 4a
(0.30 mL, 3.80 mmol). The product was obtained as a hygroscopic
foam with 97% yield. 1H NMR (400 MHz, DMSO-d6): d =
1.81–1.88 (m, 4H, CH2), 2.12 (s, 6H, CH3), 2.13 (s, 3H, CH3), 2.50
(bs, 4H, Ar–CH2), 3.86 (s, 6H, Imi-CH3), 4.28 (t, J = 7.0, 4H,
CH2-Imi), 6.77 (s, 1H), 7.74 (s, 2H, Imi), 7.88 (s, 2H, Imi), 9.25
(s, 2H, Imi) ppm. 13C NMR (100.6 MHz, DMSO-d6): d = 15.0
(CH3), 19.6 (CH3), 26.3 (Ar–CH2), 29.3 (CH2), 36.0 (Imi-CH3),
49.0 (CH2-Imi), 122.4 (Imi), 123.8 (Imi), 129.9 (CH), 133.2, 133.9,
135.3, 136.9 (Imi) ppm. ESI(+)-MS: m/z (%): 183.3 (100) [M]2+,
446.5 (3) [M + Br]+. Anal. Calcd for C23H34Br2N4·3.5 H2O: C,
46.87; H, 7.01; N, 9.51; found: C, 47.27; H, 6.89; N, 9.15.
(CH), 131.4, 133.3, 133.8, 134.5, 135.2, 137.7 (Imi), 140.5 ppm.
−1
=
IR (KBr): m = 1547 (C N) cm . ESI(+)-MS: m/z (%): 287.4
(100) [M]2+, 654.8 (8) [M + Br]+. Anal. Calcd for C39H50Br2N4·
H2O: C, 62.77; H, 7.11; N, 6.81; found: C, 62.78; H, 7.01; N, 7.09.
This journal is
The Royal Society of Chemistry 2007
Dalton Trans., 2007, 2696–2706 | 2703
©